re: #42 Patricia Kayden

Looks like they’re selling it, even at that price:

Novartis launched its gene therapy in 2019, after a groundbreaking FDA approval. With a list price of $2.125 million, Zolgensma is the most expensive medicine in the world. Novartis has said the drug’s nature as a one-time treatment and strong data support the price, and cost watchdogs on both sides of the Atlantic have agreed. So far, more than 1,800 patients have been treated with Zolgensma globally, the company said.
fiercepharma.com

No word on how many patients were treated by national health systems.

Zolgensma is owned by Novartis, whose merger components were known historically for the Tom’s River pollution scandal, and for selling LSD for MKUltra human experiments.
en.wikipedia.org